Crossref journal-article
Elsevier BV
Neuron (78)
Bibliography

Sharon, R., Bar-Joseph, I., Frosch, M. P., Walsh, D. M., Hamilton, J. A., & Selkoe, D. J. (2003). The Formation of Highly Soluble Oligomers of α-Synuclein Is Regulated by Fatty Acids and Enhanced in Parkinson’s Disease. Neuron, 37(4), 583–595.

Authors 6
  1. Ronit Sharon (first)
  2. Ifat Bar-Joseph (additional)
  3. Matthew P Frosch (additional)
  4. Dominic M Walsh (additional)
  5. James A Hamilton (additional)
  6. Dennis J Selkoe (additional)
References 37 Referenced 482
  1. 10.1016/S0896-6273(00)80886-7 / Neuron / Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system by Abeliovich (2000)
  2. 10.1126/science.1067389 / Science / Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease by Auluck (2002)
  3. {'key': '10.1016/S0896-6273(03)00024-2_BIB3', 'first-page': '879', 'article-title': "Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies", 'volume': '152', 'author': 'Baba', 'year': '1998', 'journal-title': 'Am. J. Pathol.'} / Am. J. Pathol. / Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies by Baba (1998)
  4. {'key': '10.1016/S0896-6273(03)00024-2_BIB4', 'first-page': 'E642', 'article-title': 'Muscle contractile activity increases fatty acid metabolism and transport and FAT/CD36', 'volume': '276', 'author': 'Bonen', 'year': '1999', 'journal-title': 'Am. J. Physiol.'} / Am. J. Physiol. / Muscle contractile activity increases fatty acid metabolism and transport and FAT/CD36 by Bonen (1999)
  5. 10.1016/0003-2697(76)90527-3 / Analyt. Biochem. / A rapid and sensitive method for the quantitaion of micrograms quantities of protein utilizing the principle of protein-dye binding by Bradford (1976)
  6. 10.1074/jbc.M108414200 / J. Biol. Chem. / Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein by Cole (2002)
  7. 10.1523/JNEUROSCI.12-09-03392.1992 / J. Neurosci. / A novel N18TG2 X mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin by Crawford (1992)
  8. 10.1074/jbc.273.16.9443 / J. Biol. Chem. / Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes by Davidson (1998)
  9. 10.1001/archneur.1969.00480180071006 / Arch. Neurol. / Sphingomyelin in Lewy inclusion bodies in Parkinson's disease by den Hartog Jager (1969)
  10. 10.1016/0003-9861(69)90336-1 / Arch. Biochem. Biophys. / Experimental allergic encephalomyelitis. An encephalitogenic basic protein from bovine myelin by Eylar (1969)
  11. 10.1038/35006074 / Nature / A drosophila model of Parkinson's disease by Feany (2000)
  12. 10.1006/exnr.2000.7527 / Exp. Neurol. / In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies by Gai (2000)
  13. 10.1016/0896-6273(95)90040-3 / Neuron / Characterization of a novel protein regulated during the critical period for song learning in the zebra finch by George (1995)
  14. 10.1016/S0896-6273(02)00682-7 / Neuron / Neuronal alpha-Synucleinopathy with severe movement disorder in mice expressing A53T human alpha-Synuclein by Giasson (2002)
  15. 10.1016/S0952-3278(99)80002-7 / Prostaglandins Leukot. Essent. Fatty Acids / Transport of fatty acids across membranes by the diffusion mechanism by Hamilton (1999)
  16. 10.2337/diabetes.48.12.2255 / Diabetes / How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids? by Hamilton (1999)
  17. 10.1016/S0896-6273(01)00462-7 / Neuron / beta-Synuclein inhibits alpha-synuclein aggregation by Hashimoto (2001)
  18. 10.1016/S0002-9440(10)63072-6 / Am. J. Pathol. / Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model by Kahle (2001)
  19. 10.1038/ng0298-106 / Nat. Genet. / Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease by Kruger (1998)
  20. 10.1073/pnas.132197599 / Proc. Natl. Acad. Sci. USA / Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice by Lee (2002)
  21. 10.1126/science.287.5456.1265 / Science / Dopaminergic loss and inclusion body formation in a-Synuclein mice by Masliah (2000)
  22. 10.1074/jbc.275.12.8812 / J. Biol. Chem. / Membrane association and protein conformation of a-Synuclein in intact neurons by McLean (2000)
  23. Nelson, D.L., and Cox, M.M. (2000). Lehninger Principles of Biochemistry, 3rd Edition, chapter 17 (New York: Worth Publishers).
  24. 10.1016/0003-9861(70)90361-9 / Arch. Biochem. Biophys. / Allergic encephalomyelitis by Oshiro (1970)
  25. 10.1074/jbc.M004851200 / J. Biol. Chem. / Interaction of human a-Synuclein and Parkinson's disease variants with phospholipids by Perrin (2000)
  26. 10.1074/jbc.M105022200 / J. Biol. Chem. / Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins by Perrin (2001)
  27. 10.1126/science.276.5321.2045 / Science / Mutation in the alpha-synuclein gene identified in families with Parkinson's disease by Polymeropoulos (1997)
  28. 10.1016/S0021-9258(18)35866-6 / J. Biol. Chem. / A fluorescently labeled intestinal fatty acid binding protein. Interactions with fatty acids and its use in monitoring free fatty acids by Richieri (1992)
  29. 10.1016/0092-8674(94)90252-6 / Cell / Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein by Schaffer (1994)
  30. 10.1073/pnas.171300598 / Proc. Natl. Acad. Sci. USA / alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins by Sharon (2001)
  31. 10.1016/S0014-5793(00)01563-5 / FEBS Lett. / Chaperone-like activity of synucleins by Souza (2000)
  32. 10.1038/42166 / Nature / aSynuclein in lewy bodies by Spillantini (1997)
  33. 10.1073/pnas.95.11.6469 / Proc. Natl. Acad. Sci. USA / a-Synuclein in filamentous inclusions of lewy bodies from parkinson's disease and dementia with lewy bodies by Spillantini (1998)
  34. 10.1038/416535a / Nature / Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo by Walsh (2002)
  35. 10.1038/nm0602-600 / Nat. Med. / Dopamine-dependent neurotoxicity of alpha-synuclein by Xu (2002)
  36. 10.1016/S0304-3940(97)00938-5 / Neurosci. Lett. / Chronic n-3 polyunsaturated fatty acid diet-deficiency acts on dopamine metabolism in the rat frontal cortex by Zimmer (1998)
  37. 10.1016/S0304-3940(00)00950-2 / Neurosci. Lett. / Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex by Zimmer (2000)
Dates
Type When
Created 21 years, 4 months ago (April 21, 2004, 3:12 a.m.)
Deposited 1 year, 4 months ago (April 22, 2024, 12:57 p.m.)
Indexed 1 hour, 11 minutes ago (Sept. 2, 2025, 7:10 p.m.)
Issued 22 years, 7 months ago (Feb. 1, 2003)
Published 22 years, 7 months ago (Feb. 1, 2003)
Published Print 22 years, 7 months ago (Feb. 1, 2003)
Funders 1
  1. National Institutes of Health 10.13039/100000002

    Region: Americas

    gov (National government)

    Labels3
    1. Institutos Nacionales de la Salud
    2. US National Institutes of Health
    3. NIH
    Awards1
    1. NS 38375

@article{Sharon_2003, title={The Formation of Highly Soluble Oligomers of α-Synuclein Is Regulated by Fatty Acids and Enhanced in Parkinson’s Disease}, volume={37}, ISSN={0896-6273}, url={http://dx.doi.org/10.1016/s0896-6273(03)00024-2}, DOI={10.1016/s0896-6273(03)00024-2}, number={4}, journal={Neuron}, publisher={Elsevier BV}, author={Sharon, Ronit and Bar-Joseph, Ifat and Frosch, Matthew P and Walsh, Dominic M and Hamilton, James A and Selkoe, Dennis J}, year={2003}, month=feb, pages={583–595} }